Previous 10 |
Alaunos Therapeutics, Inc. (TCRT) Q4 2021 Earnings Conference Call March 30, 2022, 08:30 AM ET Company Participants Alex Lobo - Chair IR Kevin Boyle - CEO Drew Deniger - VP, Research and Development Mike Wong - VP, Finance Conference Call Participants Chris Howerton - Jeffries Arthur He - HC ...
Alaunos Therapeutics press release (NASDAQ:TCRT): Q4 GAAP EPS of -$0.05 beats by $0.03. As of December 31, 2021, Alaunos had ~$76.1M in cash and cash equivalents. The Company anticipates its cash runway will be sufficient to fund operations into the second quarter of 2023. For further detai...
Phase 1/2 TCR-T Library trial targeting KRAS, TP53 and EGFR mutations across six solid tumor indications; first patient consented and is expected to dose in 2Q 2022 Extended CRADA with the National Cancer Institute focused on evaluating Alaunos’ TCR-T Library in a persona...
Alaunos Therapeutics (NASDAQ:TCRT) is scheduled to announce Q4 earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$0.08 (+27.3% Y/Y) Over the last 1 year, TCRT has beaten EPS estimates 0% of the time and has beaten revenue estimates 0% of the time. Ove...
AER, ATAI, BNTX, CAAS, CWCO, OTCPK:DLMAF, OTCQX:KNTNF, LGMK, MSM, ORTX, PAYX, PTE, OTCQX:TCNNF, TCRT, UPH For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Wednesday's open
HOUSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it will report financial results for the fourth quarter ended December 31, 2021 on Wednesday, March 30, 2022, before the open ...
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced that the Company’s Chief Executive Officer, Kevin S. Boyle Sr., and ...
3 Penny Stocks to Add to Your Watchlist in February If you’re making a list of penny stocks to buy, there are hundreds of options to choose from. But, because there are so many options, investors need to be picky and select the ones with the most potential. This means understandi...
News, Short Squeeze, Breakout and More Instantly...
Alaunos Therapeutics Inc. Company Name:
TCRT Stock Symbol:
NASDAQ Market:
Alaunos Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...